d-Psicose inhibits the expression of MCP-1 induced by high-glucose stimulation in HUVECs

Life Sciences

Volumn 81, Issue 7, 2007, Pages 592-599

  Murao, Koji ^a   Yu, Xiao ^a   Cao, Wen M ^a   Imachi, Hitomi ^a   Chen, Ke ^a   Muraoka, Tomie ^a   Kitanaka, Noriko ^a   Li, Junhun ^a   Ahmed, Rania A M ^a   Matsumoto, Kensuke ^a   Nishiuchi, Takamasa ^a   Tokuda, Masaaki ^b   Ishida, Toshihiko ^a  

^a Kagawa Medical University   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

d glucose; d Psicose; HUVEC; MCP 1; p38 MAPK

Indexed keywords

CHEMOKINE; GLUCOSE; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PSICOSE;

ARTICLE; ATHEROSCLEROSIS; CHEMOTAXIS; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; MONOCYTE; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FRUCTOSE; GENE EXPRESSION REGULATION; GENES, REPORTER; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STIMULATION, CHEMICAL;

EID: 34547657195     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.06.019     Document Type: Article

References (44)

1. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 4 (1991) 405-412
2. Baynes J.W., and Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48 1 (1999) 1-9
3. Begum N., and Ragolia L. HG and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. American Journal of Physiology 278 1 (2000) C81-C91
4. Brownlee M., Cerami A., and Vlassara H. Advanced glycosylation endproducts in tissue and the biochemical basis of diabetic complications. New England Journal of Medicine 318 20 (1988) 1315-1321
5. 2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. American Journal of Physiology. Heart and Circulatory Physiology 286 3 (2004) H1001-H1007
6. Ding M., Shi X., Lu Y., Huang C., Leonard S., Roberts J., Antonini J., Castranova V., and Vallyathan V. Induction of activator protein-1 through reactive oxygen species by crystalline silica in JB6 cells. Journal of Biological Chemistry 276 12 (2001) 9108-9114
7. Du X.L., Edelstein D., Rossetti L., Fantus I.G., Goldberg H., Ziyadeh F., Wu J., and Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proceedings of the National Academy of Sciences of the United States of America 97 22 (2000) 12222-12226
8. Dunlop M.E., and Muggli E.E. Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress. Kidney International 57 2 (2000) 464-475
9. Furuichi K., Wada T., Iwata Y., Sakai N., Yoshimoto K., Mukaida N., Matsushima K., and Yokoyama H. Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice. Nephrology Dialysis Transplantation 17 3 (2002) 399-407
10. Goebeler M., Kilian K., Gillitzer R., Kunz M., Yoshimura T., Bröcker E.B., Rapp U.R., and Ludwig S. Ludwig, The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood 93 3 (1999) 857-865
11. Goebeler M., Gillitzer R., Kilian K., Utzel K., Brocker E.B., Rapp U.R., and Ludwig S. Multiple signaling pathways regulate NF-kB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells. Blood 97 1 (2001) 46-55
12. Hossain M.A., Wakabayashi H., Goda F., Kobayashi S., Maeba T., and Maeta H. Effect of the immunosuppressants FK506 and d-allose on allogenic orthotopic liver transplantation in rats. Transplantation Proceedings 32 7 (2000) 2021-2023
13. Hossain M.A., Izuishi K., Tokuda M., Izumori K., and Maeta H. d-Allose has a strong suppressive effect against ischemia reperfusion injury: a comparative study with allopurinol and superoxide dismutase. Journal of Hepatobiliary Pancreatic Surgery 11 3 (2004) 181-189
14. Hotta N. New approaches for treatment in diabetes: aldose reductase inhibitors. Biomedicine & Pharmacotherapy 49 5 (1995) 232-243
15. Ido Y., Kilo C., and Williamson J.R. Cytosolic NADH/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus. Diabetologia 40 2 (1997) S115-S117
16. Igarashi M., Wakasaki H., Takahara N., Ishii H., Jiang Z.Y., Yamauchi T., Kuboki K., Meier M., Rhodes C.J., and King G.L. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. Journal of Clinical Investigation 103 2 (1999) 185-195
17. Ishii H., Koya D., and King G.L. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. Journal of Molecular Medicine 76 1 (1998) 21-31
18. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease: the Framingham Study. JAMA 241 19 (1979) 2035-2038
19. Leonard E.J., and Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunology Today 11 3 (1990) 97-101
20. Livesey G., and Brown J.C. d-Tagatose is a bulk sweetener with zero energy determined in rats. Journal of Nutrition 126 6 (1996) 1601-1609
21. Matsuo T., and Izumori K. d-Psicose, a rare sugar that provides no energy and additionally beneficial effects for clinical nutrition. Asia Pacific Journal of Clinical Nutrition 13 1 (2004) S127
22. Matsuo T., Baba Y., Hashiguchi M., Takeshita K., Izumori K., and Suzuki H. Dietary d-psicose, a C-3 epimer of d-fructose, suppresses the activity of hepatic lipogenic enzymes in rats. Asia Pacific Journal of Clinical Nutrition 10 3 (2001) 233-237
23. Matsuo T., Suzuki H., Hashiguchi M., and Izumori K. d-Psicose is a rare sugar that provides no energy to growing rats. Journal of Nutritional Science and Vitaminology 48 1 (2002) 77-80
24. Matsuo T., Tanaka T., Hashiguchi M., Izumori K., and Suzuki H. Metabolic effects of d-psicose in rats: studies on faecal and urinary excretion and caecal fermentation. Asia Pacific Journal of Clinical Nutrition 12 2 (2003) 225-231
25. Momoi A., Murao K., Imachi H., Nakamura H., Hosokawa H., Sato M., Fujita J., Okada H., Ishida T., and Takahara J. Thiazolidinedione inhibits production of RANTES in a cytokine-treated human lung epithelial cell line. FEBS Letters 452 3 (1999) 301-304
26. Momoi A., Murao K., Imachi H., Ishida T., Cao W.M., Sato M., and Takahara J. Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione. Chest 120 4 (2001) 1293-1300
27. Muniruzzaman S., Pan Y.T., Zeng Y., Atkins B., Izumori K., and Elbein A.D. Inhibition of glycoprotein processing by l-fructose and l-xylulose. Glycobiology 6 8 (1996) 795-803
28. Murao K., Wada Y., Nakamura T., Taylor A.H., Mooradian A.D., and Wong N.C. Effects of glucose and insulin on rat apolipoprotein A-I gene expression. Journal of Biological Chemistry 273 30 (1998) 18959-18965
29. Murao K., Imachi H., Momoi A., Sayo Y., Hosokawa H., Sato M., Ishida T., and Takahara J. Thiazolidinedione inhibits the production of monocyte chemoattractant protein-1 in cytokine-treated human vascular endothelial cells. FEBS Letters 454 1-2 (1999) 27-30
30. Murata A., Sekiya K., Watanabe Y., Yamaguchi F., Hatano N., Izumori K., and Tokuda M. A novel inhibitory effect of Dallose on production of reactive oxygen species from neutrophils. Journal of Bioscience and Bioengineering 96 5 (2003) 8991
31. Navab M., Imes S.S., Hama S.Y., Hough G.P., Ross L.A., Bork R.W., Valente A.J., Berliner J.A., Drinkwater D.C., Laks H., and Fogelman A.M. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. Journal of Clinical Investigation 88 6 (1991) 2039-2046
32. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 6779 (2000) 787-790
33. Pugliese G., Tilton R.G., and Williamson J.R. Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes/Metabolism Reviews 7 1 (1991) 35-59
34. Rollins B.J., Yoshimura T., Leonard E.J., and Pober J.S. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. American Journal of Pathology 136 6 (1990) 1229-1233
35. Salituro F.G., Germann U.A., Wilson K.P., Bemis G.W., Fox T., and Su M.S. Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases. Current Medicinal Chemistry 6 9 (1999) 807-823
36. Schall T.J., and Bacon K.B. Chemokines, leukocyte trafficking, and inflammation. Current Opinion in Immunology 6 6 (1994) 865-873
37. Shanmugam N., Reddy M.A., Guha M., and Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52 5 (2003) 1256-1264
38. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 2 (1993) 434-444
39. Surapisitchat J., Hoefen R.J., Pi X., Yoshizumi M., Yan C., and Berk B.C. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members. Proceedings of the National Academy of Sciences of the United States of America 98 11 (2001) 6476-6481
40. Takaishi H., Taniguchi T., Takahashi A., Ishikawa Y., and Yokoyama M. High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells. Biochemical and Biophysical Research Communications 305 1 (2003) 122-128
41. Takata M.K., Yamaguchi F., Nakanose K., Watanabe Y., Hatano N., Tsukamoto I., Nagata M., Izumori K., and Tokuda M. Neuroprotective effect of d-psicose on 6-hydroxydopamine-induced apoptosis in rat pheochromocytoma (PC12) cells. Journal of Bioscience and Bioengineering 100 5 (2005) 511-516
42. Terkeltaub R., Boisvert W.A., and Curtiss L.K. Chemokines and atherosclerosis. Current Opinion in Lipidology 9 5 (1998) 397-405
43. Ushio-Fukai M., Alexander R.W., Akers M., and Griendling K.K. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. Journal of Biological Chemistry 273 24 (1998) 15022-15029
44. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., Sarkioja T., Yoshimura T., Leonard E.J., Witztum J.L., and Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proceedings of the National Academy of Sciences of the United States of America 88 12 (1991) 5252-5256